Boron Neutron Clinical Trial Recruitment enrolls at Dongguan People's Hospital (Dongguan Hospital) .
Dongguan Hospital (Dongguan Municipal People's Hospital) has enclosed a 4,000-square-meter site in the Honglou hospital area, and the construction of the "D-BNCT" treatment center building is accelerating in full swing. It is expected that the "BNCT" equipment will be installed on site during the year, and clinical trials will be conducted in the first half of 2022. In the future, Dongguan will have the first BNCT treatment center with full intellectual property rights.
The treatment starts with injecting patients with a boron-containing drug, which has a strong affinity for cancer cells, and will quickly gather in the cancer cells, which is equivalent to "marking" the cancer cells, while distributing them in few other tissues. The patient is then given neutron irradiation, which lasts less than an hour, and the whole treatment process usually requires only one irradiation.
When the irradiated neutrons are captured by the boron inside the cancer cells, highly lethal alpha particles and lithium ions are generated, which can precisely "kill" the cancer cells. Boron Neutron Capture Therapy (BNCT) is one of the most advanced cancer treatments in the world, which can selectively destroy cancer cells without causing serious damage to normal cells.
The above content reference: Dongguan People's Hospital Boron Neutron Capture Therapy Program Acceleration